News

Warren Buffett makes money without even trying. How? His Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) portfolio is loaded with dividend stocks.

Some of Berkshire's holdings don't generate an

The Nasdaq-100 is having an incredible year. It has delivered a gain of 51.9% so far, marking a sharp reversal from 2022 when it plunged into bear territory.

But a gain of more than 50% in a single

When a company underperforms, the markets sometimes have a tendency to overreact. An earnings miss or a guidance cut can at times be enough to lead to a significant sell-off, even if the underlying

Priced at less than 8 times next year's expected per-share earnings, there's no denying Ford Motor Company (NYSE: F) stock offers tremendous value right now. The dividend yield of 5% isn't too

Spurred by market-moving trends, including the rise of artificial intelligence (AI), 2023 has been a great year for growth stocks. Explosive gains for companies including Nvidia, Microsoft, and

Fool.com contributor Parkev Tatevosian highlights the excellent prospects DraftKings (NASDAQ: DKNG) has in 2024 and answers if that's enough to make the stock a buy for long-term investors.

*Stock

Dutch Bros (NYSE: BROS) is effectively trying to take on industry giants like Dunkin and Starbucks (NASDAQ: SBUX). Although that's a "grande" order, so far the upstart seems to be doing fairly well

Energy drink company Celsius Holdings (NASDAQ: CELH) has stormed onto Wall Street. Shares are up more than 4,370% over the past five years. The company disrupted a competitive beverage industry and

A new year is approaching, and that means investors are about to start hearing a lot more about dogs. That's because of the popular investing strategy called "the Dogs of the Dow," which focuses on

Investing on Wall Street can sometimes be a roller coaster of emotions. The COVID-19 crash in February-March 2020 was the quickest bear market decline in history. Meanwhile, the rallies growth-stock

Fortune recently published its Future 50 List for 2023, an annual ranking of the world's largest companies based on long-term growth prospects. Software vendors shaping the future of artificial

With investing, you have to get started somewhere, and $500 is a great place to begin. The key, however, is to build a foundation for the future with that cash.

Yes, you could buy a stock, but a

Soaring interest rates have been a major headwind for NextEra Energy (NYSE: NEE) and affiliate NextEra Energy Partners (NYSE: NEP). Higher rates have made it more expensive for companies to borrow

Once you need to start pulling money out of your retirement accounts to cover your costs of living, your relationship with your investments changes. Because you need to have readily available money

An investment of just $100 made in shares of Nvidia (NASDAQ: NVDA) five years ago is now worth about $1,339, which is not surprising as the market has rewarded the chipmaker's impressive growth in

It's hard not to be bullish about Advanced Micro Devices (NASDAQ: AMD). The company's stock has more than doubled in 2023, up some 115% since Jan. 1. Meanwhile, it appears to be making promising

Dividend stocks can be excellent sources of recurring income for your portfolio. Stocks that increase their payouts over time can be even more valuable for long-term investors, as this income could

Though volatility is inherent on Wall Street, things have been especially erratic over the past four years. The COVID-19 crash, 2022 bear market, and investment euphoria of 2021 all whipsawed

Innovation creates new businesses that stock investors can capitalize on for gains. While credit for such opportunities often goes to the technology industry, investors may overlook the consumer

There are different benefits to entering retirement as part of a married couple. For one thing, you'll have someone to spend your days with once you're no longer working. And ideally, you'll have

CRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The company and partner Vertex Pharmaceuticals delivered positive results from clinical trials of their